In conclusion, the expression of SETMAR in thyroid cancer is stabilized by METTL3‐mediated m6A modification in an IGF2BP3‐dependent manner, which could explain its dysregulation during dedifferentiation of thyroid cancer. This evidence concerns the gene METTL3 and thyroid gland carcinoma.